Used in solid-phase peptide synthesis as a protected amino acid building block, enabling the incorporation of a methoxy-modified aromatic amino acid into peptide chains. The Fmoc group allows for mild base deprotection, making it compatible with orthogonal protection strategies. Its structure supports the development of bioactive peptides with enhanced stability or receptor selectivity, particularly in pharmaceutical research and the synthesis of enzyme inhibitors or peptide-based probes. The electron-donating methoxy group can influence peptide conformation and aromatic interactions in designed sequences.